Racial background is a determinant factor in the maintenance dosage of warfarin

被引:65
作者
Gan, GG [1 ]
Teh, A [1 ]
Goh, KY [1 ]
Chong, HT [1 ]
Pang, KW [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia
关键词
racial background; warfarin;
D O I
10.1007/BF02983247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Warfarin is a drug commonly used in the prevention of thromboembolic events. There have been reports suggesting that racial background may influence warfarin dose requirements. Malaysia is a multiracial country in which there are 3 major races, Malay, Chinese, and Indian. We examined 100 patients from our hospital on stable maintenance doses of warfarin, with international normalized ratio (INR) of 2.0 to 3.5. We found that the mean warfarin dose for Indian patients (n = 19) was 6.9 mg, for Chinese patients (n = 55) was 3.6 mg, and for Malay patients (n = 26) was 3.2 mg. The results showed that the Indian patients required a statistically significantly higher warfarin dose than did patients of the other 2 races (P<.0005). Age was also found to affect the daily warfarin maintenance dose. (C) 2003 The Japanese Society of Hematology.
引用
收藏
页码:84 / 86
页数:3
相关论文
共 8 条
  • [1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
    Aithal, GP
    Day, CP
    Kesteven, PJL
    Daly, AK
    [J]. LANCET, 1999, 353 (9154) : 717 - 719
  • [2] Racial background is a determinant of average warfarin dose required to maintain the INR between 2•0 and 3•0
    Blann, A
    Hewitt, J
    Siddiqui, F
    Bareford, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) : 207 - 209
  • [3] EFFECT OF AGE UPON THE INDUCTION AND MAINTENANCE OF ANTICOAGULATION WITH WARFARIN
    GLADMAN, JRF
    DOLAN, G
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1995, 71 (833) : 153 - 155
  • [4] Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
    Goldstein, JA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) : 349 - 355
  • [5] FACTORS AFFECTING THE MAINTENANCE DOSE OF WARFARIN
    JAMES, AH
    BRITT, RP
    RASKINO, CL
    THOMPSON, SG
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (08) : 704 - 706
  • [6] Pharmacogenetics of warfarin elimination and its clinical implications
    Takahashi, H
    Echizen, H
    [J]. CLINICAL PHARMACOKINETICS, 2001, 40 (08) : 587 - 603
  • [7] Yu HCM, 1996, QJM-MON J ASSOC PHYS, V89, P127
  • [8] DIFFERENCES IN PLASMA-BINDING OF DRUGS BETWEEN CAUCASIANS AND CHINESE SUBJECTS
    ZHOU, HH
    ADEDOYIN, A
    WILKINSON, GR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) : 10 - 17